All lobbying filings

WALGREEN COMPANY

WALGREEN COMPANY filed a Q1 amendment for WALGREEN COMPANY on July 27, 2026.

Lobbying for WALGREEN COMPANY

All filings by WALGREEN COMPANY · Everything WALGREEN COMPANY has reported

Filing · LD-2 quarterly report Q1 amendment

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Jul 27, 2026

Expenses

$330,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Pharmacy

- H.R.3164: Ensuring Community Access to Pharmacist Services Act: Issues related to access to pharmacist services - Issues related to 340B - Issues related to vaccine access

Consumer Issues/Safety/Products

- H.R. 2853/S.1404: The Combatting Organized Retail Crime Act: Issues related to preventing organized retail crime

Taxation/Internal Revenue Code

- Work Opportunity Tax Credit

Bills named in this filing 3

H.R. 3164
Ensuring Community Access to Pharmacist Services Act
H.R. 2853
Combating Organized Retail Crime Act of 2025
S. 1404
Combating Organized Retail Crime Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.